Zhang Fan, Ding Jun, Luo Man, Luo Hao-Hua, Sun Xiao-Lin, Fang Xu, Chen Lei, Tao Jun, Zhu Zhao-Qiong
Department of Anesthesiology Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Department of Anesthesiology Qian Xi Nan People's Hospital Qianxinan Guizhou China.
Ibrain. 2022 May 10;8(2):165-175. doi: 10.1002/ibra.12039. eCollection 2022 Summer.
Ketamine may become an important drug for multimodal analgesia regime again because of its strong analgesic effects and retaining the advantage of spontaneous breathing. The present study was designed to explore the influences of different dosages of S-ketamine anesthesia induction regimes on psychiatric complications and postoperative prognosis in patients undergoing gynecological operations. In this prospective, triple-blinded, randomized, controlled study, patients undergoing elective gynecological surgery were randomized to one of three treatment groups: low-dose S-ketamine (LDSK) group (a 0.3 mg/kg bolus for anesthesia induction), minimal-dose S-ketamine (MDSK) group (a 0.2 mg/kg bolus for anesthesia induction), and placebo (CON) group (a saline bolus for anesthesia induction). The main outcome measures were as follows: intraoperative vital signs, extubation time, anesthesia recovery time and postanesthesia care unit (PACU) stay duration, incidence of psychiatric complications, Ramsay sedation scale (RSS) 1, 2, 24, and 48 h, postoperatively, and overall prognosis. One hundred and eighty female participants were finally included in this study from April 2021 to December 2021. Significant differences were not observed in age, height, weight, American Society of Anesthesiologists physical status classification, or history of mental illness between the groups. No statistically significant differences were discovered with regard to intraoperative vital signs, extubation time and PACU stay duration, incidence of psychiatric complications, and RSS scores at 1, 2, 24, and 48 h postoperatively in the three groups. However, the visual analog scale (VAS) scores of the CON group at 10 min after extubation and at the time point leaving PACU were much higher than that of the LDSK and MDSK groups. The VAS scores at 48 h after surgery in the MDSK group were also lower than that of the CON group and the CON group had received more analgesic drug treatment in the surgical wards consequently. Postoperative nausea and vomiting (PONV) occurrence at 24 and 48 h, postoperatively, increased sharply in the CON group than in the other two experimental groups, which led to an increase in the use of postoperative antiemetic drugs in this group. According to the postoperative satisfaction survey, patients in the CON group had lower medical satisfaction. Our data demonstrate that a small dosage of S-ketamine anesthesia induction can reduce postoperative pain and the incidence of PONV without increasing hemodynamic fluctuations or psychiatric complications.
由于氯胺酮具有强大的镇痛作用且能保留自主呼吸的优势,它可能会再次成为多模式镇痛方案中的一种重要药物。本研究旨在探讨不同剂量的S-氯胺酮麻醉诱导方案对妇科手术患者精神并发症及术后预后的影响。在这项前瞻性、三盲、随机、对照研究中,择期妇科手术患者被随机分为三个治疗组之一:低剂量S-氯胺酮(LDSK)组(麻醉诱导推注剂量为0.3mg/kg)、最小剂量S-氯胺酮(MDSK)组(麻醉诱导推注剂量为0.2mg/kg)和安慰剂(CON)组(麻醉诱导推注生理盐水)。主要观察指标如下:术中生命体征、拔管时间、麻醉恢复时间及麻醉后监护病房(PACU)停留时间、精神并发症发生率、术后1、2、24和48小时的 Ramsay 镇静评分(RSS)以及总体预后。2021年4月至2021年12月,本研究最终纳入了180名女性参与者。各组在年龄、身高、体重、美国麻醉医师协会身体状况分级或精神疾病史方面未观察到显著差异。三组在术中生命体征、拔管时间和PACU停留时间、精神并发症发生率以及术后1、2、2、24和48小时的RSS评分方面均未发现统计学上的显著差异。然而,CON组在拔管后10分钟和离开PACU时的视觉模拟评分(VAS)显著高于LDSK组和MDSK组。MDSK组术后48小时的VAS评分也低于CON组,因此CON组在手术病房接受了更多的镇痛药物治疗。术后24和48小时,CON组的术后恶心呕吐(PONV)发生率比其他两个实验组急剧增加,这导致该组术后止吐药物的使用增加。根据术后满意度调查,CON组患者的医疗满意度较低。我们的数据表明,小剂量的S-氯胺酮麻醉诱导可减轻术后疼痛和PONV的发生率,而不会增加血流动力学波动或精神并发症。